Kane Biotech (KNBIF, $0.04) was a top loser over the last three months, falling to $0.04 per share. A.I.dvisor analyzed 832 stocks in the Biotechnology Industry for the 3-month period ending June 4, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.